Diane Harper, M.D., joined representatives from the World Health Organization in a presentation August 29 in Montreal for the World Cancer Congress – Union for International Cancer Control, which represents the largest network dedicated to global cancer control. Dr. Harper, Professor of Medicine in the UMKC Departments of Community and Family Medicine, Obstetrics and Gynecology, and […]
Researchers in the Department of Ophthalmology at the University of Missouri-Kansas City School of Medicine have received a four-year challenge grant of $220,000 from Research to Prevent Blindness, the leading voluntary health organization supporting eye research directed at the prevention, treatment or eradication of all diseases that threaten vision. The research will be directed by […]
The University of Missouri-Kansas City has received a $400,000 gift to establish a pulmonary fibrosis research program at the UMKC School of Medicine. The gift comes from the estate of the late Mary K. Geldmacher, a retired St. Louis school teacher who suffered from pulmonary fibrosis and passed away in 2009. Pulmonary fibrosis is the […]
The University of Missouri-Kansas City School of Medicine has received a five-year, $1.5 million grant from the National Heart, Lung and Blood Institute at the National Institutes of Health to provide a postdoctoral fellowship program in cardiovascular outcomes research. The program will be based at Saint Luke’s Mid America Heart Instituteand is designed to meet […]
Researchers at the University of Missouri-Kansas City (UMKC) School of Medicine have been awarded a grant from the National Institutes of Health for research that could lead to improved treatment and prevention of cocaine addiction. Researchers in the lab of Xiang-Ping Chu, M.D., Ph.D., assistant professor of Basic Medical Science at the School of Medicine, […]
The medical journal, Lancet Onclology, has published a commentary by Diane Harper, M.D., Professor in the UMKC Departments of Community and Family Medicine, Obstetrics and Gynecology, Informatics and Personalized Health. Dr. Harper’s comments are in response to a study reported in the journal suggesting that bivalent human papillomavirus (HPV) vaccine used in the routine vaccination […]
NIH Funding Opportunities NSF Program Announcements